Parameters influencing the course of passive drug loading into lipid nanoemulsions

Graphical abstract Figure. No Caption available. ABSTRACT Passive drug loading can be used to effectively identify suitable colloidal lipid carrier systems for poorly water‐soluble drugs. This method comprises incubation of preformed carrier systems with drug powder and subsequent determination of the resulting drug load of the carrier particles. Until now, the passive loading mechanism is unknown, which complicates reliable routine use. In this work, the influence of drug characteristics on the course of passive loading was investigated systematically varying drug surface area and drug solubility. Fenofibrate and flufenamic acid were used as model drugs; the carrier system was a trimyristin nanodispersion. Loading progress was analyzed by UV spectroscopy or by a novel method based on differential scanning calorimetry. While increasing drug solubility by micelle incorporation did not speed up passive loading, a large drug surface area and high water solubility were key parameters for fast loading. Since both factors are crucial in drug dissolution as described by the Noyes‐Whitney equation, these findings point to a dissolution‐diffusion‐based passive loading mechanism. Accordingly, passive loading also occurred when drug and carrier particles were separated by a dialysis membrane. Knowledge of the loading mechanism allows optimizing the conditions for future passive loading studies and assessing the limitations of the method.

[1]  Heike Bunjes,et al.  Lipid nanoparticles for the delivery of poorly water‐soluble drugs , 2010, The Journal of pharmacy and pharmacology.

[2]  M. Roller,et al.  Mass Transport Phenomena in Lipid Oxidation and Antioxidation. , 2017, Annual review of food science and technology.

[3]  Wei-Guo Dai,et al.  Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation. , 2008, Advanced drug delivery reviews.

[4]  Jochem Alsenz,et al.  Miniaturized Assay for Solubility and Residual Solid Screening (SORESOS) in Early Drug Development , 2007, Pharmaceutical Research.

[5]  F. Tiberg,et al.  Drug delivery applications of non-lamellar liquid crystalline phases and nanoparticles , 2011 .

[6]  H. Bunjes,et al.  Drug release studies from lipid nanoparticles in physiological media by a new DSC method , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Tsuyoshi Murata,et al.  {m , 1934, ACML.

[8]  Heike Bunjes,et al.  Lipid nanoparticles: drug localization is substance-specific and achievable load depends on the size and physical state of the particles. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Alexander V. Kabanov,et al.  Micelle formation and solubilization of fluorescent probes in poly(oxyethylene-b-oxypropylene-b-oxyethylene) solutions , 1995 .

[10]  P. van Hoogevest,et al.  Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[11]  S. Majumdar,et al.  Injectable Lipid Emulsions—Advancements, Opportunities and Challenges , 2010, AAPS PharmSciTech.

[12]  K. Mäder,et al.  Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.

[13]  R. Müller,et al.  SolEmuls-novel technology for the formulation of i.v. emulsions with poorly soluble drugs. , 2004, International journal of pharmaceutics.

[14]  Peter Van Hoogevest,et al.  Instant solubilization of poorly water-soluble drugs by in-situ loading of aqueous phospholipid dispersions suitable for parenteral administration. , 2006, PDA journal of pharmaceutical science and technology.

[15]  L. Miller,et al.  Modeling the influence of cyclodextrins on oral absorption of low‐solubility drugs: I. Model development , 2010, Biotechnology and bioengineering.

[16]  L. S. Wan,et al.  CMC of polysorbates. , 1974, Journal of pharmaceutical sciences.

[17]  Manfred Kansy,et al.  High throughput solubility measurement in drug discovery and development. , 2007, Advanced drug delivery reviews.

[18]  B. Shekunov Theoretical Analysis of Drug Dissolution in Micellar Media. , 2017, Journal of pharmaceutical sciences.

[19]  P. Cullis,et al.  Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.

[20]  Control over Particle Size Distribution by Autoclaving Poloxamer-Stabilized Trimyristin Nanodispersions. , 2016, Molecular pharmaceutics.

[21]  Paul D Leeson,et al.  Molecular inflation, attrition and the rule of five. , 2016, Advanced drug delivery reviews.

[22]  L. Miller,et al.  Modeling the influence of cyclodextrins on oral absorption of low solubility drugs: II. Experimental validation , 2010, Biotechnology and bioengineering.

[23]  Gordon L Amidon,et al.  Dissolution and Solubility Behavior of Fenofibrate in Sodium Lauryl Sulfate Solutions , 2005, Drug development and industrial pharmacy.

[24]  H. Bunjes,et al.  Supercooled Smectic Nanoparticles: A Potential Novel Carrier System for Poorly Water Soluble Drugs , 2004, Pharmaceutical Research.

[25]  Hywel D Williams,et al.  Strategies to Address Low Drug Solubility in Discovery and Development , 2013, Pharmacological Reviews.

[26]  Rebecca Lyn Carrier,et al.  Predicting the Effect of Fed-State Intestinal Contents on Drug Dissolution , 2010, Pharmaceutical Research.

[27]  Heike Bunjes,et al.  Incorporation of the Model Drug Ubidecarenone into Solid Lipid Nanoparticles , 2001, Pharmaceutical Research.

[28]  Heike Bunjes,et al.  Evaluation of the drug loading capacity of different lipid nanoparticle dispersions by passive drug loading , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[29]  Heike Bunjes,et al.  Parenteral formulation of an antileishmanial drug candidate--tackling poor solubility, chemical instability, and polymorphism. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  L. Deriemaeker,et al.  Ostwald ripening and solubilization in alkane in water emulsions stabilized by different surfactantsPresented at the 17th Conference of the European Colloid & Interface Science Society, Firenze, Italy, September 21?26, 2003. , 2004 .

[31]  Ingo Ott,et al.  Alkynyl gold(I) phosphane complexes: Evaluation of structure-activity-relationships for the phosphane ligands, effects on key signaling proteins and preliminary in-vivo studies with a nanoformulated complex. , 2016, Journal of inorganic biochemistry.

[32]  Heike Bunjes,et al.  Crystallization tendency and polymorphic transitions in triglyceride nanoparticles , 1996 .